Rachubik Patrycja, Szrejder Maria, Rogacka Dorota, Audzeyenka Irena, Rychłowski Michał, Angielski Stefan, Piwkowska Agnieszka
Mossakowski Medical Research Centre Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Gdańsk, Poland.
University of Gdańsk - Medical University of Gdańsk, Intercollegiate Faculty of Biotechnology, Laboratory of Virus Molecular Biology, Gdańsk, Poland.
Cell Physiol Biochem. 2018;51(1):393-410. doi: 10.1159/000495236. Epub 2018 Nov 19.
BACKGROUND/AIMS: Podocytes are dynamic polarized cells on the surface of glomerular capillaries that are an essential part of the glomerular filtration barrier. AMP-activated protein kinase (AMPK), a key regulator of glucose and fatty acid metabolism, plays a major role in obesity and type 2 diabetes. Accumulating evidence suggests that TRPC6 channels are crucial mediators of calcium transport in podocytes and are involved in regulating glomerular filtration. Here we investigated whether the AMPK-TRPC6 pathway is involved in insulin-dependent cytoskeleton reorganization and glucose uptake in cultured rat podocytes.
Western blot and immunofluorescence analysis confirmed AMPKα and TRPC6 expression, the phosphorylation of proteins associated with actin cytoskeleton reorganization (PAK, rac1, and cofilin), and the expression of insulin signaling proteins (Akt, Insulin receptor). Coimmunoprecipitation and immunofluorescence results demonstrated AMPKα/TRPC6 interaction. To ask whether TRPC6 is involved in the insulin regulation of glucose transport, we measured insulin-dependent (1, 2-3H)-deoxy-D-glucose uptake into podocytes after reducing TRPC6 activity pharmacologically and biochemically (TRPC6 siRNA).
The results suggested a key role for the TRPC6 channel in the mediation of insulin-dependent activation of AMPKα2 and glucose uptake. Moreover, AMPK and TRPC6 activation were required to stimulate the Rac1 signaling pathway.
These results suggest a potentially important new mechanism that regulates glucose transport in podocytes and that could be injurious during diabetes.
背景/目的:足细胞是肾小球毛细血管表面动态极化的细胞,是肾小球滤过屏障的重要组成部分。AMP激活的蛋白激酶(AMPK)是葡萄糖和脂肪酸代谢的关键调节因子,在肥胖和2型糖尿病中起主要作用。越来越多的证据表明,瞬时受体电位通道6(TRPC6)是足细胞钙转运的关键介质,参与调节肾小球滤过。在此,我们研究了AMPK-TRPC6通路是否参与培养的大鼠足细胞中胰岛素依赖的细胞骨架重组和葡萄糖摄取。
蛋白质印迹法和免疫荧光分析证实了AMPKα和TRPC6的表达、与肌动蛋白细胞骨架重组相关蛋白(PAK、rac1和丝切蛋白)的磷酸化以及胰岛素信号蛋白(Akt、胰岛素受体)的表达。免疫共沉淀和免疫荧光结果证明了AMPKα/TRPC6的相互作用。为了探究TRPC6是否参与胰岛素对葡萄糖转运的调节,我们在通过药理学和生物化学方法降低TRPC6活性(TRPC6小干扰RNA)后,测量了足细胞中胰岛素依赖的(1,2-3H)-脱氧-D-葡萄糖摄取。
结果表明TRPC6通道在介导胰岛素依赖的AMPKα2激活和葡萄糖摄取中起关键作用。此外激活AMPK和TRPC6是刺激Rac1信号通路所必需的。
这些结果提示了一种潜在的重要新机制,该机制调节足细胞中的葡萄糖转运,并且在糖尿病期间可能具有损害作用。